1018818-04-6

Basic information

• Product Name: (2R,4S)-1-Boc-4-Methylpyrrolidine-2-carboxylic acid
• Synonyms: (2R,4S)-1-Boc-4-Methylpyrrolidine-2-carboxylic acid;(2r,4s)-1-[(tert-butoxy)carbonyl]-4-methylpyrrolidine-2-carboxylic acid
• CAS NO: 1018818-04-6
• Molecular Formula: C11H19NO4
• Molecular Weight: 229.27286
• Mol File: 1018818-04-6.mol

Chemical Properties

• Boiling Point: 343.2±35.0 °C(Predicted)
• Appearance: /
• Density: 1.150±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 4.02±0.40(Predicted)
• CAS DataBase Reference: (2R,4S)-1-Boc-4-Methylpyrrolidine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,4S)-1-Boc-4-Methylpyrrolidine-2-carboxylic acid(1018818-04-6)
• EPA Substance Registry System: (2R,4S)-1-Boc-4-Methylpyrrolidine-2-carboxylic acid(1018818-04-6)

Safety Data

• Hazardous Substances Data: 1018818-04-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(2R,4S)-1-Boc-4-Methylpyrrolidine-2-carboxylic acid serves as a key building block in organic synthesis, specifically for the production of various drugs and pharmaceutical intermediates. Its unique stereochemistry plays a vital role in determining the compound's biological activity, making it an essential component in the development of effective medications.
As a chiral compound, (2R,4S)-1-Boc-4-Methylpyrrolidine-2-carboxylic acid is particularly valuable in the synthesis of enantiomerically pure compounds, which are crucial for the pharmaceutical industry to ensure the desired therapeutic effects and minimize potential side effects. Its systematic name, N-[(2R,4S)-4-Methyl-2-pyrrolidinyl]-2-methylpropanamide, and abbreviation, (R,S)-Boc-4-Me-Proline, further highlight its significance in the field of organic chemistry and drug development.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 879374-48-8 (5R,3S)-1-tert-butoxycarbonyl-5-carboxymethyl-3-methyl-2-pyrrolidinone 
• 879374-49-9 (2R,4S)-1-tert-butoxycarbonyl-2-carboxymethyl-4-methylpyrrolidine 

Downstream Products

• 879374-50-2 (2R,4S)-1-(9-fluorenylmethoxycarbonyl)-4-methylpyrrolidine-2-carboxylic acid 

Relevant articles and documents

Total synthesis, NMR solution structure, and binding model of the potent histone deacetylase inhibitor FR235222

An alternative route: The fungal metabolite FR235222, a potent inhibitor of mammalian histone deacetylase (HDAC), has been synthesized. Key steps are the preparation of unusual amino acids Ahoda and (2R,4S)-MePro. A 3D model for cyclopeptide inhibitor int

Isoquinoline compound and pharmaceutical use thereof

The present invention relates to an isoquinoline compound represented by the following formula (I), an optically active form thereof, a pharmaceutically acceptable salt thereof, a water adduct thereof, a hydrate thereof and a solvate thereof, as well as an agent for the prophylaxis and/or treatment of a disease caused by hyperreactivity of poly(ADP-ribose)polymerase, containing the compound, and a poly(ADP-ribose)polymerase inhibitor containing the compound. In addition, this compound is useful as an agent for the prophylaxis and/or treatment of cerebral infarction, particularly as an agent for the prophylaxis and/or treatment of acute cerebral infarction. Furthermore, this compound is useful as a prophylactic and/or therapeutic agent that improves neurological symptoms associated with cerebral infarction, particularly acute cerebral infarction. wherein the symbols are the same as defined in the description.